Laboratoires Euromedis Société anonyme Valuation

Q: What is the Fair Price of ALEMG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

ALEMG (€4.57) is trading below our estimate of [[fair value]] (€7.51)

Is ALEMG undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ALEMG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ALEMG (€4.57) is trading below our estimate of fair value (€7.51)

Significantly Below Fair Value: ALEMG is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ALEMG?

Key metric: As ALEMG is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for ALEMG. This is calculated by dividing ALEMG's market cap by their current earnings.
What is ALEMG's PE Ratio?
PE Ratio	0.7x
Earnings	€18.15m
Market Cap	€13.02m

ALEMG key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.1x
Enterprise Value/EBITDA	-8.8x
PEG Ratio	-0.008x

Price to Earnings Ratio vs Peers

How does ALEMG's PE Ratio compare to its peers?

The above table shows the PE ratio for ALEMG vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	56x
ALTER Theradiag	39x	n/a	€16.4m
ALKLH Klea Holding	31.6x	n/a	€52.9m
AMPLI Amplitude Surgical	96.1x	n/a	€149.7m
MLLAB Media Lab	57.4x	n/a	€5.2m
ALEMG Laboratoires Euromedis Société anonyme	0.7x	-90.1%	€13.0m

Price-To-Earnings vs Peers: ALEMG is good value based on its Price-To-Earnings Ratio (0.7x) compared to the peer average (56x).

Price to Earnings Ratio vs Industry

How does ALEMG's PE Ratio compare vs other companies in the European Medical Equipment Industry?

3 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	29.1x	15.4%
ALEMG Laboratoires Euromedis Société anonyme	0.7x	-90.1%	US$13.69m

3 Companies		Estimated Growth	Market Cap
Industry Avg.	29.1x	15.4%
ALEMG Laboratoires Euromedis Société anonyme	0.7x	-90.1%	US$13.69m

No more companies

Price-To-Earnings vs Industry: ALEMG is good value based on its Price-To-Earnings Ratio (0.7x) compared to the European Medical Equipment industry average (29.1x).

Price to Earnings Ratio vs Fair Ratio

What is ALEMG's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ALEMG PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	0.7x
Fair PE Ratio	1.3x

Price-To-Earnings vs Fair Ratio: ALEMG is good value based on its Price-To-Earnings Ratio (0.7x) compared to the estimated Fair Price-To-Earnings Ratio (1.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Equasens Société anonyme

€625.3m

Provides healthcare IT solutions in Europe.

EQS

€40.70

-7.1%

-29.1%

emeis Société anonyme

€901.5m

Operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals.

EMEIS

€5.21

-10.7%

-98.3%

Ramsay Générale de Santé

€1.3b

Operates healthcare facilities in France, Sweden, Norway, Denmark, and Italy.

GDS

€11.50

-5.0%

-43.3%